Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000384279 | SCV000335658 | uncertain significance | not provided | 2015-10-01 | criteria provided, single submitter | clinical testing | |
Knight Diagnostic Laboratories, |
RCV000384279 | SCV001448963 | uncertain significance | not provided | 2019-10-09 | criteria provided, single submitter | clinical testing | |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV000384279 | SCV002051609 | uncertain significance | not provided | 2021-03-03 | criteria provided, single submitter | clinical testing | No ACMG evidence could be applied applied |
Invitae | RCV000384279 | SCV002329915 | likely benign | not provided | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004547681 | SCV004779025 | likely benign | COL18A1-related disorder | 2023-01-30 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Laboratory of Diagnostic Genome Analysis, |
RCV000384279 | SCV001799434 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000384279 | SCV001975877 | uncertain significance | not provided | no assertion criteria provided | clinical testing |